BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35011618)

  • 21. The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.
    Nikpour P; Baygi ME; Steinhoff C; Hader C; Luca AC; Mowla SJ; Schulz WA
    J Cell Mol Med; 2011 May; 15(5):1210-24. PubMed ID: 20477901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway.
    Chen K; Gao Q; Zhang W; Liu Z; Cai J; Liu Y; Xu J; Li J; Yang Y; Xu X
    Liver Int; 2015 Mar; 35(3):986-98. PubMed ID: 24444033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of miR-124 inhibits growth of medulloblastoma cells.
    Silber J; Hashizume R; Felix T; Hariono S; Yu M; Berger MS; Huse JT; VandenBerg SR; James CD; Hodgson JG; Gupta N
    Neuro Oncol; 2013 Jan; 15(1):83-90. PubMed ID: 23172372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
    Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO
    Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor.
    Li M; Lockwood W; Zielenska M; Northcott P; Ra YS; Bouffet E; Yoshimoto M; Rutka JT; Yan H; Taylor MD; Eberhart C; Hawkins CE; Lam W; Squire JA; Huang A
    Cancer Genet; 2012 May; 205(5):220-31. PubMed ID: 22682621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of GPR137 suppresses proliferation of medulloblastoma cells in vitro.
    Wang C; Liang Q; Chen G; Jing J; Wang S
    Biotechnol Appl Biochem; 2015; 62(6):868-73. PubMed ID: 25524330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.
    Jin Y; Xiong A; Zhang Z; Li S; Huang H; Yu TT; Cao X; Cheng SY
    Oncotarget; 2014 Jul; 5(13):4821-33. PubMed ID: 24970811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
    Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI
    Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.
    Laneve P; Po A; Favia A; Legnini I; Alfano V; Rea J; Di Carlo V; Bevilacqua V; Miele E; Mastronuzzi A; Carai A; Locatelli F; Bozzoni I; Ferretti E; Caffarelli E
    Oncotarget; 2017 May; 8(19):31003-31015. PubMed ID: 28415684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LIN28 expression and function in medulloblastoma.
    Maklad A; Sedeeq M; Wilson R; Heath JA; Gueven N; Azimi I
    J Cell Physiol; 2023 Mar; 238(3):533-548. PubMed ID: 36649308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
    Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
    Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
    Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the Neural RNA-binding protein Musashi1 in pediatric brain tumors.
    Nakano A; Kanemura Y; Mori K; Kodama E; Yamamoto A; Sakamoto H; Nakamura Y; Okano H; Yamasaki M; Arita N
    Pediatr Neurosurg; 2007; 43(4):279-84. PubMed ID: 17627143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.
    Patil S; Sankpal UT; Hurtado M; Bowman WP; Murray J; Borgmann K; Ghorpade A; Sutphin R; Eslin D; Basha R
    Gene; 2019 Jul; 705():67-76. PubMed ID: 30991098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.
    Venkataraman S; Alimova I; Balakrishnan I; Harris P; Birks DK; Griesinger A; Amani V; Cristiano B; Remke M; Taylor MD; Handler M; Foreman NK; Vibhakar R
    Oncotarget; 2014 May; 5(9):2355-71. PubMed ID: 24796395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tumor cell migration and invasion through knockdown of Rac1 expression in medulloblastoma cells.
    Chen B; Gao Y; Jiang T; Ding J; Zeng Y; Xu R; Jiang X
    Cell Mol Neurobiol; 2011 Mar; 31(2):251-7. PubMed ID: 21076938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
    Kameda-Smith MM; Zhu H; Luo EC; Suk Y; Xella A; Yee B; Chokshi C; Xing S; Tan F; Fox RG; Adile AA; Bakhshinyan D; Brown K; Gwynne WD; Subapanditha M; Miletic P; Picard D; Burns I; Moffat J; Paruch K; Fleming A; Hope K; Provias JP; Remke M; Lu Y; Reya T; Venugopal C; Reimand J; Wechsler-Reya RJ; Yeo GW; Singh SK
    Nat Commun; 2022 Dec; 13(1):7506. PubMed ID: 36473869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells.
    Oehler C; von Bueren AO; Furmanova P; Broggini-Tenzer A; Orlowski K; Rutkowski S; Frei K; Grotzer MA; Pruschy M
    Neuro Oncol; 2011 Sep; 13(9):1000-10. PubMed ID: 21743064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.
    Milde T; Lodrini M; Savelyeva L; Korshunov A; Kool M; Brueckner LM; Antunes AS; Oehme I; Pekrun A; Pfister SM; Kulozik AE; Witt O; Deubzer HE
    J Neurooncol; 2012 Dec; 110(3):335-48. PubMed ID: 23054560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.